2-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 250mg

[(E)-2-Phenylvinyl]boronic acid, 250mg

(R)-4-Amino-2-ethylisoxazolidin-3-one hydrochloride, 97%, 1g

4,4'-(Benzo[c][1,2,5]thiadiazole-4,7-diyl)dibenzoic acid, 97%, 5g

4-chloro-6-(4-methyl-1H-pyrazol-1-yl)pyrimidine, 95.0%, 1g

5,6-DIMETHOXY-1H-INDAZOLE, 95%, 5g

Methyl 2-(4-(chlorosulfonyl)phenoxy)acetate, 95.0%, 250mg

Methyl 2-methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate, 98%, 5g

2-Bromo-4,5-dimethoxybenzaldehyde, 97.0%, 25g

N*1*,N*1*-Dimethyl-1-p-tolyl-ethane-1,2-diamine, 95.0%, 5g

(3-(Cyclopentylcarbamoyl)phenyl)boronic acid, 95.0%, 5g

Récipient à col large, 70 ml, 100 Pièce(s)

1,3-Bis(benzo[d][1,3]dioxol-4-yl)urea, 95.0%, 1g